Lana holds an MSc in medical science from the University of Toronto and has 3+ years of experience in pharmaceutical market access consulting. She has a profound understanding of administrative health databases, RWE, HTA, pCPA, payers, and PMPRB. Her passion lies in using data-driven insights to inform strategic decision-making within the healthcare space. Lana has supported clients and their products to achieve reimbursement success by conducting landscape assessments, advisory boards, payer research, data analysis, and reimbursement submissions. She is highly familiar with a wide variety of therapeutic areas, including oncology, non-oncology, cell & gene therapies, DRDs, biosimilars, and diagnostic devices.